EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway
- PMID: 28705113
- DOI: 10.1177/1010428317706203
EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway
Abstract
Growth hormone-secreting pituitary adenoma accounts for about 20% of the third most common intracranial neoplasm-pituitary adenomas-which makes up 15% of all intracranial tumors. The growth hormone-secreting pituitary adenoma invasion is a key risk factor associated with the operation results and highly correlated with the clinical prognosis. The epidermal growth factor-like domain multiple 7 protein, a unique 29 kDa secreted angiogenic factor, can result in pathologic angiogenesis and enhance the tumor migration and invasion. In this study, for the first time we found that epidermal growth factor-like domain multiple 7 protein expression was markedly higher in invasive growth hormone-secreting pituitary adenoma than non-invasive growth hormone-secreting pituitary adenoma. The tumor volume, histologic subtypes, invasiveness and recurrence of growth hormone-secreting pituitary adenoma were significantly associated with epidermal growth factor-like domain multiple 7 protein expression. Furthermore, we discovered that the histological classification methods of growth hormone-secreting pituitary adenoma according to electron microscopic examination and biological marker classification methods according to epidermal growth factor-like domain multiple 7 protein expression are more valuable in clinical application than the traditional classification methods based on Knosp and Hardy-Wilson grades. In summary, our results indicated epidermal growth factor-like domain multiple 7 protein participates in growth hormone-secreting pituitary adenoma proliferation and invasion regulation via Notch2/DLL3 signaling pathway. These findings raised the possibility that epidermal growth factor-like domain multiple 7 protein might serve as a useful biomarker to assess growth hormone-secreting pituitary adenoma invasion and prognosis or a potential therapeutic target for growth hormone-secreting pituitary adenoma treatment.
Keywords: Epidermal growth factor–like domain multiple 7 protein; growth hormone-secreting pituitary adenomas; invasion; notch signaling pathway; proliferation.
Similar articles
-
Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.Sci China Life Sci. 2018 Aug;61(8):893-901. doi: 10.1007/s11427-018-9320-4. Epub 2018 Jun 26. Sci China Life Sci. 2018. PMID: 29951953
-
Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.Endocrine. 2016 Jun;52(3):632-40. doi: 10.1007/s12020-015-0802-8. Epub 2015 Nov 17. Endocrine. 2016. PMID: 26578364
-
Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.Oncol Rep. 2016 May;35(5):2991-9. doi: 10.3892/or.2016.4650. Epub 2016 Mar 3. Oncol Rep. 2016. PMID: 26935389
-
[Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Dec;34(6):640-4. doi: 10.3881/j.issn.1000-503X.2012.06.021. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012. PMID: 23286415 Review. Chinese.
-
Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.Endocrinol Metab Clin North Am. 2015 Mar;44(1):19-25. doi: 10.1016/j.ecl.2014.10.002. Epub 2014 Nov 4. Endocrinol Metab Clin North Am. 2015. PMID: 25732638 Review.
Cited by
-
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy.Cancers (Basel). 2023 Nov 6;15(21):5301. doi: 10.3390/cancers15215301. Cancers (Basel). 2023. PMID: 37958474 Free PMC article. Review.
-
Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling.Cell Commun Signal. 2023 Jul 21;21(1):180. doi: 10.1186/s12964-023-01200-6. Cell Commun Signal. 2023. PMID: 37480091 Free PMC article.
-
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.Int J Mol Sci. 2023 Jun 30;24(13):10952. doi: 10.3390/ijms241310952. Int J Mol Sci. 2023. PMID: 37446128 Free PMC article. Review.
-
Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.Front Genet. 2023 May 18;14:1098190. doi: 10.3389/fgene.2023.1098190. eCollection 2023. Front Genet. 2023. PMID: 37274780 Free PMC article.
-
Elevated DLL3 in stomach cancer by tumor-associated macrophages enhances cancer-cell proliferation and cytokine secretion of macrophages.Gastroenterol Rep (Oxf). 2021 Nov 25;10:goab052. doi: 10.1093/gastro/goab052. eCollection 2022. Gastroenterol Rep (Oxf). 2021. PMID: 35382168 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
